<body><a name="drugname"></a><table class="topbox" width="100%">
<tr>
<td><span class="topboxgenname">LEVOCABASTINE HYDROCHLORIDE <img border="0" src="../images/pr.gif"/></span><br/>(lev-o-ca-bas'teen)<br/><span class="topboxtradename">Livostin<br/></span><b>Classifications:</b> <span class="classification">eye preparation</span>; <span class="classification">ocular antihistamine</span>; <span class="classification">h<sub>1</sub>-receptor antagonist</span><br/><b>Pregnancy Category: </b>C<br/></td>
</tr>
</table>
<h1><a name="avail">Availability</a></h1>
<p>0.05% ophthalmic suspension</p>
<h1><a name="action">Actions</a></h1>
<p>Potent antihistamine that competes for H<sub>1</sub>-receptor sites on effector cells, thus blocking histamine release.
      </p>
<h1><a name="therapef">Therapeutic Effects</a></h1>
<p>Blocks histamine release as an antihistamine H<sub>1</sub> receptor antagonist.
      </p>
<h1><a name="uses">Uses</a></h1>
<p>Temporary relief of seasonal allergic conjunctivitis.</p>
<h1><a name="contrain">Contraindications</a></h1>
<p>Hypersensitivity to levocabastine, soft contact lenses.</p>
<h1><a name="precaution">Cautious Use</a></h1>
<p>Hypersensitivity to other antihistamines, kidney disease, pregnancy (category C), or lactation. Safety and efficacy in children
         
      </p><h1><a name="rtedsg">Route &amp; Dosage</a></h1>
<table cellpadding="4" cellspacing="0" class="rdbox" width="100%">
<tr>
<td><span class="indicationtitle">Allergic Conjunctivitis</span><br/><span class="rdage">Adult:</span> <span class="rdroute">Ophthalmic</span> 1 drop in affected eye q.i.d.<br/></td>
</tr>
</table>
<h1><a name="admintn">Administration</a></h1><span class="adminroutetype">Instillation</span><br/><ul>
<li>Shake well before using. Apply drops in the center of the lower conjunctional sac. Do not touch eyelids with dropper.</li>
<li>Store in a tightly closed bottle. Do not use if discolored.</li>
</ul>
<h1><a name="adverse">Adverse Effects (<img src="../images/special/greaterorequal.gif"/>1%)</a></h1><span class="typehead">CNS:</span> Drowsiness, fatigue, headache. <span class="typehead">GI:</span> Dry mouth. <span class="typehead">Special Senses:</span>
<span class="speceff-common">Ocular irritation, mild transient stinging and burning,</span> conjunctival congestion, eyelid edema, eye pain, photophobia, abnormal lacrimation. 
      <h1><a name="interactions">Interactions</a></h1><span class="typehead"> Drug:</span>  No clinically significant interactions established. 
      <h1><a name="pharmaks">Pharmacokinetics</a></h1><span class="typehead">Absorption:</span> Significant systemic absorption; 3060% reaches systemic circulation. <span class="typehead">Onset:</span> 15 min. <span class="typehead">Duration:</span> 4 h. <span class="typehead">Distribution:</span> Slight distribution into breast milk. <span class="typehead">Metabolism:</span> Minimal metabolism in liver. <span class="typehead">Elimination:</span> 6573% excreted in urine unchanged; up to 20% excreted in bile. <span class="typehead">Half-Life:</span> 3340 h. 
      <h1><a name="nursing"><span class="implictitle">Nursing Implications</span></a></h1>
<p><span class="adeffecttitle">Assessment &amp; Drug Effects</span></p>
<ul>
<li>Monitor for S&amp;S of hypersensitivity to the drug (see Appendix F).</li>
<li>Evaluate safety of engaging in hazardous activities since drowsiness is a potential adverse effect.</li>
</ul>
<p><span class="eductitle">Patient &amp; Family Education</span></p>
<ul>
<li>Learn potential adverse responses to drug.</li>
<li>Eye drops contain benzalkonium chloride, which may damage soft contact lenses.</li>
<li>Do not breast feed while using this drug without consulting physician.</li>
</ul>
<hr/>
<p><span class="footer">Common adverse effects in <i>italic</i>, life-threatening effects <u>underlined</u>; generic names in <b>bold</b>; classifications in <small>SMALL CAPS</small>; <img border="0" src="../images/maple.gif"/> Canadian drug name; <img border="0" src="../images/pr.gif"/> Prototype drug</span></p>
</body>